Bevacizumab: Revision history

From IDWiki

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    17 March 2022

    • curprev 07:2607:26, 17 March 2022Aidan talk contribs 538 bytes +538 Created page with "* Recombinant humanized IgG1 anti-VEGF monoclonal antibody * Indications include advanced colorectal cancer, non-small cell lung cancer, breast cancer, and renal cancer ** May..." Tag: Visual edit